VTGN Stock Analysis: Buy, Sell, or Hold?

VTGN - Vistagen Therapeutics, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.62
-0.01 (-2.17%) ▼
5d: -10.36%
30d: -4.4%
90d: +0.37%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026

Get Alerted When VTGN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR STABILIZATION: VTGN is down 10.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: VTGN is currently trading at $0.62, which is considered fair relative to its 30-day fair value range of $0.56 to $0.66.

Technical Outlook: Technically, VTGN is showing sideways momentum. Immediate support is located at $0.52, while resistance sits at $0.66.

Market Sentiment: VTGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $0.97 (+52.9%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.56 - $0.66
Company Quality Score 59/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 52.9% below Wall St target ($0.97)
  • WARNING: Recommendation downgraded due to -10.4% 5-day decline - wait for stabilization

Trading Range Analysis

30-Day Trading Range $0.56 - $0.66
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $0.52
Resistance Level $0.66
Current Trend Sideways
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -0.65
Wall Street Target $0.97 (+52.9%)
Revenue Growth (YoY) 29.5%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 24, 2026 10:22 AM ET
Data refreshes hourly during market hours. Next update: 11:22 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for VTGN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RARE
Ultragenyx
STRONG BUY
20 analysts
$52 64 BUY
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$105 62 BUY
VKTX
Viking Therapeutics Inc
STRONG BUY
19 analysts
$93 65 BUY
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$83 61 BUY
INCY
Incyte Corporation
HOLD
27 analysts
$109 60 BUY

More Analysis for VTGN

VTGN Technical Chart VTGN Price Prediction VTGN Earnings Date VTGN Investment Advisor VTGN Fair Price Analyzer VTGN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals